Results of Long Term Iron Chelation Treatment with Deferoxamine
- 1 January 2002
- book chapter
- Published by Springer Nature
- Vol. 509, 91-125
- https://doi.org/10.1007/978-1-4615-0593-8_6
Abstract
No abstract availableKeywords
This publication has 158 references indexed in Scilit:
- Prolonged survival in patients with beta-thalassemia major treated with deferoxamineThe Journal of Pediatrics, 1991
- Rapid removal of excessive iron with daily, high-dose intravenous chelation therapyThe Journal of Pediatrics, 1989
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982
- Response to long-term deferoxamine therapy in thalassemiaThe Journal of Pediatrics, 1981
- Depressed serum somatomedin activity in β-thalassemiaThe Journal of Pediatrics, 1980
- Detection of Early Cardiac Dysfunction in Patients with Severe Beta-Thalassemia and Chronic Iron OverloadNew England Journal of Medicine, 1979
- Glucose homeostasis in children with severe cyanotic congenital heart diseaseThe Journal of Pediatrics, 1979
- Enteritis, abscess, and septicemia due to Yersiniaenterocolitica in a child with thalassemiaThe Journal of Pediatrics, 1978
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978